EMJ GOLD: Pharma news, views and analysis

Uncover the latest customer expectations of medical affairs in this episode of the GOLD podcast, which sees the team speak with not one but two MA leaders from top healthcare consultancy firm, ZS. Join guests Sarah Jarvis, Global Lead for the Medical Consulting Practice, and Sunil John, Principal and Co-Lead Global Medical Affairs Practice, as they delve into ZS's latest medical affairs outlook report. Find out what customers want from omnichannel, lifecycle medical education preferences and so much more. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: Revealing the true value of medical affairs 5 ways pharma can ensure omnichannel success The ZS medical outlook report 2023 Last week's episode: Translating policy into action

Explore how the pharmaceutical industry can turn diversity, equality and inclusion initiatives into transformational change in the latest episode of the GOLD podcast, where Jade Williams talks to Anita Ralli, Director, Government Affairs, Inclusion and Diversity, Employee Resource Group Lead, Gilead Sciences UK. In this episode, Jade picks the brains of our guest to find out how companies can attract diverse talent to their workforce, key ways to create an environment where employees can be themselves and how to ensure Employee Resource Groups are successful. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: Podcast: Pharma, Pride and the LGBTQ+ community Podcast: International Women's Day 2023 special My journey with diversity, equity and inclusion - Davidek Herron 4 top tips to create the perfect employee resource group Last week's episode: Meet GOLD's new catalyst – CSL Behring's Karen Pinachyan

In this week's episode, Isabel and Jade share some snippets from the interview with GOLD's next catalyst Karen Pinachyan, Head of Medical Affairs, Europe, CSL Behring. In this teaser edition of the full interview, Karen shares his motivation for joining the pharmaceutical industry, his thoughts on how to shift the care paradigm towards personalised medicine and how he believes both industry and healthcare systems can work together to deliver more value to patients. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: Mapping a path to personalised medicine Revealing the true value of medical affairs Podcast: Is medical affairs the Ferrari of the pharma industry? Last week's episode: Shaping success in cell therapy

As the US celebrates the 4th of July today, navigate the evolving landscape of cell therapy with hosts Isabel and Jade as they present an insightful discussion with Warner Biddle, Senior Vice President and Global Head of Commercial, Kite, a Gilead Company. Tune in to hear Warner discuss why creating equitable patient access is a 'team sport', the potential barriers to advancing cell therapy and what he would choose as his TED Talk topic. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: Cell and gene therapy: a victim of its own success https://www.emg-gold.com/post/cell-and-gene-therapy-a-victim-of-its-own-success Mapping a path to personalised medicine https://www.emg-gold.com/post/mapping-a-path-to-personalised-medicine Podcast: Driving access to all medicines https://www.emg-gold.com/post/driving-access-to-all-medicines Last week's episode: Pharma, Pride and the LGBTQ+ community https://www.emg-gold.com/post/pharma-pride-and-the-lgbtq-community

This week, as we approach the end of Pride Month, the GOLD team looks into how the industry can proactively support patients and staff who are part of the LGBTQ+ community. Join Isabel and Jade as they look at how the industry can avoid 'rainbow washing' and tokenism to drive a positive change both inside and outside their organisations. This will include highlighting effective initiatives from BMS, GSK, Genetech and Pfizer, who like many others, are committed to supporting the community during Pride Month and beyond. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: Confronting health inequities for transgender patients Reverse mentoring: a how-to guide 4 top tips to create the perfect ERG Last week's episode: What will it take to transform cancer care?

Explore the industry's evolving mission to advance cancer research and care in this new episode of the GOLD podcast with hosts Isabel and Jade, featuring an insightful conversation with Dr Sunil Verma, Global Head of Oncology, Medical, AstraZeneca. In this episode, Isabel uncovers Sunil's passion for working in oncology, his analysis of where cancer care has been and where it is going, why personalised medicine is the ultimate goal for oncology and an insight into the challenge that can keep him up at night. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: Mapping a path to personalised medicine Christi Shaw on her drive to develop innovative cancer treatments Mental health matters in pharma's approach to care Last week's episode: Powering the new commercial model

Tune in to the next episode of the GOLD podcast to hear the team's latest conversation with a leading figure in the pharmaceutical industry. What is being discussed this week? The industry's evolving commercial model. In this week's episode, Isabel chats with Chetak Buaria, Vice President of Global Commercial Operations, Oncology, Merck Group, about how a new model driven by technology and data is in sight. The two explore what this new model might look like, whether pharma is ready for it and how to move forward without alienating internal or external stakeholders. The opinions and views expressed here are his personal and do not necessarily reflect the opinions or views of Merck Healthcare KGaA, Germany or any subsidiary thereof. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: Tipping the scales of KOL success Conquering generational differences in HCP marketing Is the pharma rep at death's door? Last week's episode: Getting to grips with customer experience

Join Isabel and Jade in kicking off Season 5 of the GOLD podcast with this brand-new episode, which sees the pair return to the airwaves to share more brilliant insights from experts in the pharmaceutical industry. In this first episode, Isabel discusses customer experience with Philippe Kirby, Global Head of Channel Engagement and Execution, MSD. In the conversation, Philippe reveals what pharma is getting right and wrong, how to get valuable and actionable feedback from customers, how to balance customer experience and compliance and much more. All views are Philippe's own and not those of his company. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: Upgrading the personal touch in CX Crafting customer experience 5 ways pharma can ensure omnichannel success

The GOLD team are delighted to announce that Season 5 of The GOLD Podcast is just around the corner. To mark the run up to the next series, Isabel and Jade take a moment in this episode to reminisce about some of the hot topics our brilliant guests shared with us in Season 4. Join our hosts as they journey through their 'GOLD medal moments' from last season, covering topics such as the rise of AI, the importance of empathy in leadership, the fight for representation in organisations and more. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: Behind the hype of ChatGPT: https://www.emg-gold.com/post/behind-the-hype-of-chatgpt Taking women to the top of pharma: https://www.emg-gold.com/post/taking-women-to-the-top-of-pharma Raising women's health up the agenda: https://www.emg-gold.com/post/raising-women-s-health-up-the-agenda Medical affairs, AI and insight generation: https://www.emg-gold.com/post/medical-affairs-ai-and-insight-generation

To mark the final episode of Season 4, Isabel and Jade reminisce about their favourite moments from the series and give an exclusive teaser for the next issue of GOLD – out on 13 April. Expect discussion on topics such as the current state of life sciences innovation in the UK, the latest advances and potential of personalised medicine, a deep dive into our Catalyst interview with Christi Shaw, former CEO, Kite Pharma, and lots of bonus insights from the writers themselves. Be sure to subscribe here to receive the full issue straight to your inbox on publication day. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: Pharma in the UK Mapping a path to personalised medicine